Effect of β-blocker on clinical outcomes in patients with traumatic brain injury: a retrospective propensity-matched study
β-blocker therapy is associated with improved short-term outcomes in patients with TBI, particularly in those with mild (GCS 13-15) and severe (GCS 3-8) TBI. However, no significant benefit was observed in patients with moderate TBI (GCS 9-12). This therapy may also prolong hospital and ICU stays.
Authors
- Wenwen Ji
- Tingting Liu (ORCID: https://orcid.org/0000-0001-6396-7225)
- Yaxin Zhang (ORCID: https://orcid.org/0000-0002-9533-1472)
- Guangdong Wang (ORCID: https://orcid.org/0000-0001-7237-3517)
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.3389/fphar.2025.1465657
- Citations
- 2
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 2.78